Skip to main content

Table 2 Correlations of disease activity assessments with serum trough level of adalimumab and etanercept

From: High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritis

Adalimumab

Correlation coefficient (ρ)

P-value

ASDAS CRP

-0.16

0.39

BASDAI

-0.14

0.43

CRP

0.002

0.99

Etanercept

Correlation coefficient (ρ)

P-value

ASDAS CRP

-0.29

0.20

BASDAI

-0.17

0.47

CRP

-0.23

0.31

  1. Abbreviations: see Table 1
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us